Heme oxygenase-1 prevents non-alcoholic steatohepatitis through suppressing hepatocyte apoptosis in mice

Lipids in Health and Disease

Volumn 9, Issue , 2010, Pages

  Kong, Li ^a   Nan, Yuemin ^a   Wang, Rongqi ^a   Zhao, Suxian ^a   Han, Fang ^a   Wu, Wen Juan ^a   Kong, Lingbo ^a   Fu, Na ^a   Yu, Jun ^b  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 9; CHOLINE; CYTOCHROME C; CYTOCHROME P450 2E1; FAS ANTIGEN; FAS LIGAND; HEME OXYGENASE 1; HEMIN; MESSENGER RNA; METHIONINE; PROTEIN BAX; PROTEIN BCL 2; PROTOPORPHYRIN ZINC; PROTOPORPHYRIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL STRAIN HEK293; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; LIPID PEROXIDATION; LIVER CELL; LIVER HISTOLOGY; LIVER INJURY; LIVER PROTECTION; MALE; MOUSE; NICK END LABELING; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; FATTY LIVER; GENETICS; PHYSIOLOGY;

ADENOVIRIDAE; MUS;

ANIMALS; APOPTOSIS; FATTY LIVER; HEME OXYGENASE-1; HEMIN; HEPATOCYTES; IN SITU NICK-END LABELING; MALE; METHIONINE; MICE; MICE, INBRED C57BL; PROTOPORPHYRINS;

EID: 77958526937     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-9-124     Document Type: Article

References (47)

1. The relationship between apoptosis and non-alcoholic fatty liver disease: an evolutionary cornerstone turned pathogenic. A Canbay RK Gieseler GJ Gores G Gerken, Z Gastroenterol 2005 43 211 217 10.1055/s-2004-813744 15700216
2. Adipokines and cytokines in non-alcoholic fatty liver disease. MH Jarrar A Baranova R Collantes B Ranard M Stepanova C Bennett Y Fang H Elariny Z Goodman V Chandhoke ZM Younossi, Aliment Pharmacol Ther 2008 27 412 421 10.1111/j.1365-2036.2007.03586.x 18081738
3. Mechanisms of disease progression in nonalcoholic fatty liver disease. J Jou SS Choi AM Diehl, Semin Liver Dis 2008 28 370 379 10.1055/s-0028-1091981 18956293
4. Pathogenesis of non-alcoholic steatohepatitis: human data. J Edmison AJ McCullough, Clin Liver Dis 2007 11 75 104 10.1016/j.cld.2007.02.011 17544973
5. Mitochondrial dysfunction and oxidative stress in the pathogenesis of alcohol- and obesity-induced fatty liver diseases. SK Mantena AL King KK Andringa HB Eccleston SM Bailey, Free Radic Biol Med 2008 44 1259 1272 10.1016/j.freeradbiomed.2007.12.029 18242193
6. Increased apoptosis in high-fat diet-induced nonalcoholic steatohepatitis in rats is associated with c-Jun NH2-terminal kinase activation and elevated proapoptotic Bax. Y Wang LM Ausman RM Russell AS Greenberg XD Wang, J Nutr 2008 138 1866 1871 18806094
7. Apoptosis and Cytokines in Non-Alcoholic Steatohepatitis. WK Syn SS Choi AM Diehl AM Diehl, Clin Liver Dis 2009 13 565 580 10.1016/j.cld.2009.07.003 19818305
8. Induction and regulation of hepatocyte apoptosis by oxidative stress. MJ Czaja, Antioxid Redox Signal 2002 4 759 767 10.1089/152308602760598909 12470503
9. Highly liver-specific heme oxygenase-1 induction by interleukin-11 prevents carbon tetrachloride-induced hepatotoxicity. T Kawakami T Takahashi H Shimizu K Nakahira M Takeuchi H Katayama M Yokoyama K Morita R Akagi S Sassa, Int J Mol Med 2006 18 537 546 16964402
10. rAAV-mediated stable expression of heme oxygenase-1 in stellate cells: a new approach to attenuate liver fibrosis in rats. TY Tsui CK Lau J Ma X Wu YQ Wang S Farkas R Xu HJ Schlitt ST Fan, Hepatology 2005 42 335 342 10.1002/hep.20803 16025519
11. Heme oxygenase-1: a fundamental guardian against oxidative tissue injuries in acute inflammation. T Takahashi H Shimizu H Morimatsu K Inoue R Akagi K Morita S Sassa, Mini Rev Med Chem 2007 7 745 753 10.2174/ 138955707781024517 17627585
12. Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. SW Ryter J Alam AM Choi, Physiol Rev 2006 86 583 650 10.1152/physrev.00011.2005 16601269
13. Protective functions of heme oxygenase-1 and carbon monoxide in the respiratory system. SW Ryter HP Kim K Nakahira BS Zuckerbraun D Morse AM Choi, Antioxid Redox Signal 2007 9 2157 2173 10.1089/ars.2007.1811 17845132
14. Carbon monoxide and bilirubin: potential therapies for pulmonary/vascular injury and disease. SW Ryter D Morse AM Choi, Am J Respir Cell Mol Biol 2007 36 175 182 10.1165/rcmb.2006-0333TR 16980550
15. Regulation of human heme oxygenase in endothelial cells by using sense and antisense retroviral constructs. S Quan L Yang NG Abraham A Kappas, Proc Natl Acad Sci USA 2001 98 12203 12208 10.1073/pnas.211399398 11593038
16. Heme oxygenase-1 prevents superoxide anion-associated endothelial cell sloughing in diabetic rats. S Quan PM Kaminski L Yang T Morita M Inaba S Ikehara AI Goodman MS Wolin NG Abraham, Biochem Biophys Res Commun 2004 315 509 516 10.1016/j.bbrc.2004.01.086 14766238
17. Rosiglitazone prevents nutritional fibrosis and steatohepatitis in mice. YM Nan N Fu WJ Wu BL Liang RQ Wang SX Zhao JM Zhao J Yu, Scand J Gastroenterol 2009 44 358 365 10.1080/00365520802530861 18991162
18. Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis. AE Feldstein A Canbay P Angulo M Taniai LJ Burgart KD Lindor GJ Gores, Gastroenterology 2003 125 437 443 10.1016/S0016-5085(03) 00907-7 12891546
19. Oxalate modulates thiobarbituric acid reactive species (TBARS) production in supernatants of homogenates from rat brain, liver and kidney: effect of diphenyl diselenide and diphenyl ditelluride. RL Puntel DH Roos MW Paixo AL Braga G Zeni CW Nogueira JB Rocha, Chem Biol Interact 2007 165 87 98 10.1016/j.cbi.2006.11.003 17188671
20. Antioxidants vitamin E and 1-aminobenzotriazole prevent experimental non-alcoholic steatohepatitis in mice. YM Nan WJ Wu N Fu BL Liang RQ Wang LX Li SX Zhao JM Zhao J Yu, Scand J Gastroenterol 2009 44 1121 1131 10.1080/00365520903114912 19606393
21. Apoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expression. GC Farrell CZ Larter JY Hou RH Zhang MM Yeh J Williams A dela Pena R Francisco SR Osvath J Brooling N Teoh LM Sedger, J Gastroenterol Hepatol 2009 24 443 452 10.1111/j.1440-1746.2009.05785.x 19226377
22. Zinc protoporphyrin IX, a heme oxygenase-1 inhibitor, demonstrates potent antitumor effects but is unable to potentiate antitumor effects of chemotherapeutics in mice. D Nowis M Bugajski M Winiarska J Bil A Szokalska P Salwa T Issat H Was A Jozkowicz J Dulak T Stoklosa J Golab, BMC Cancer 2008 8 197 10.1186/1471-2407-8-197 18620555
23. Nonalcoholic fatty liver disease: an overview of current insights in pathogenesis, diagnosis and treatment. TC Schreuder BJ Verwer CM van Nieuwkerk CJ Mulder, World J Gastroenterol 2008 14 2474 2486 10.3748/wjg.14.2474 18442193
24. Induction of the permeability transition and cytochrome c release by 15-deoxy-Delta12, 14-prostaglandin J2 in mitochondria. A Landar S Shiva AL Levonen JY Oh C Zaragoza MS Johnson VM Darley-Usmar, Biochem J 2006 394 Pt1 185 195 16268779
25. Alcohol metabolism's damaging effects on the cell: a focus on reactive oxygen generation by the enzyme cytochrome P450 2E1. DR Koop, Alcohol Res Health 2006 29 274 280 17718406
26. Regulation of CYP2E1 by ethanol and palmitic acid and CYP4A11 by clofibrate in primary cultures of human hepatocytes. JL Raucy J Lasker K Ozaki V Zoleta, Toxicol Sci 2004 79 233 241 10.1093/toxsci/kfh126 15056802
27. Mitochondrial dysfunction and oxidative stress in the pathogenesis of alcohol- and obesity-induced fatty liver diseases. SK Mantena AL King KK Andringa HB Eccleston SM Bailey, Free Radic Biol Med 2008 44 1259 1272 10.1016/j.freeradbiomed.2007.12.029 18242193
28. Heme oxygenase-1 suppresses hepatitis C virus replication and increases resistance of hepatocytes to oxidant injury. Z Zhu AT Wilson MM Mathahs F Wen KE Brown BA Luxon WN Schmidt, Hepatology 2008 48 1430 1439 10.1002/hep.22491 18972446
29. The relationship between apoptosis and non-alcoholic fatty liver disease: an evolutionary cornerstone turned pathogenic. A Canbay RK Gieseler GJ Gores G Gerken, Z Gastroenterol 2005 43 211 217 10.1055/s-2004-813744 15700216
30. Hepatocyte apoptosis, expression of death receptors, and activation of NF-kappaB in the liver of nonalcoholic and alcoholic steatohepatitis patients. PS Ribeiro H Cortez Pinto S Sola RE Castro RM Ramalho A Baptista MC Moura ME Camilo CM Rodrigues, Am J Gastroenterol 2004 99 1708 1717 10.1111/j.1572-0241. 2004.40009.x 15330907
31. Regulation of hepatocyte apoptosis by oxidative stress. R Singh MJ Czaja, J Gastroenterol Hepatol 2007 22 S1 45 S48 10.1111/j.1440-1746.2006.04646.x 17567464
32. The "fuzzy logic" of the death-inducing signaling complex in lymphocytes. CM Walsh KA Luhrs AF Arechiga, J Clin Immunol 2003 23 333 353 10.1023/A:1025313415487 14601642
33. Heme oxygenase-1, a critical arbitrator of cell death pathways in lung injury and disease. D Morse L Lin AM Choi SW Ryter, Free Radic Biol Med 2009 47 1 12 10.1016/j.freeradbiomed.2009.04.007 19362144
34. The apoptosome: signaling platform of cell death. SJ Riedl GS Salvesen, Nat Rev Mol Cell Biol 2007 8 405 413 10.1038/nrm2153 17377525
35. Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal. K Lauber E Bohn SM Krober YJ Xiao SG Blumenthal RK Lindemann P Marini C Wiedig A Zobywalski S Baksh Y Xu IB Autenrieth K Schulze-Osthoff C Belka G Stuhler S Wesselborg, Cell 2003 113 717 730 10.1016/S0092-8674(03)00422-7 12809603
36. Molecular mechanisms of caspase regulation during apoptosis. SJ Riedl Y Shi, Nat Rev Mol Cell Biol 2004 5 897 907 10.1038/nrm1496 15520809
37. Initiator caspases in apoptosis signaling pathways. M Chen J Wang, Apoptosis 2002 7 313 319 10.1023/A:1016167228059 12101390
38. Heme oxygenase-1 and its reaction product, carbon monoxide, prevent inflammation-related apoptotic liver damage in mice. G Sass MC Soares K Yamashita, Hepatology 2003 38 909 918 14512878
39. Heme oxygenase-1 enhances renal mitochondrial transport carriers and cytochrome c oxidase activity in experimental diabetes. MA Di Noia S Van Driesche F Palmieri LM Yang S Quan AI Goodman NG Abraham, J Biol Chem 2006 281 15687 15693 10.1074/jbc.M510595200 16595661
40. Genetic suppression of HO-1 exacerbates renal damage: reversed by an increase in the antiapoptotic signaling pathway. R Olszanecki R Rezzani S Omura DE Stec L Rodella FT Botros AI Goodman G Drummond NG Abraham, Am J Physiol Renal Physiol 2007 292 148 F157 10.1152/ajprenal.00261.2006 16940561
41. Impact of silencing HO-2 on EC-SOD and the mitochondrial signaling pathway. S Turkseven G Drummond R Rezzani L Rodella S Quan S Ikehara NG Abraham, J Cell Biochem 2007 100 815 823 10.1002/jcb.21138 17131376
42. Exogenous biliverdin ameliorates ischemia-reperfusion injury in small-for-size rat liver grafts. LM Tang YP Wang K Wang LY Pu F Zhang XC Li LB Kong BC Sun GQ Li XH Wang, Transplant Proc 2007 39 1338 1344 10.1016/j.transproceed.2006.11.032 17580135
43. Ferritin and the response to oxidative stress. K Orino L Lehman Y Tsuji H Ayaki SV Torti FM Torti, Biochem J 2001 357 241 247 10.1042/0264-6021:3570241 11415455
44. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. LE Otterbein FH Bach J Alam M Soares H Tao Lu M Wysk RJ Davis RA Flavell AM Choi, Nat Med 2000 6 422 428 10.1038/74680 10742149
45. Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis. S Brouard LE Otterbein J Anrather E Tobiasch FH Bach AM Choi MP Soares, J Exp Med 2000 192 1015 1026 10.1084/jem.192.7.1015 11015442
46. Heme oxygenase-1-derived carbon monoxide requires the activation of transcription factor NF-kappa B to protect endothelial cells from tumor necrosis factor-alpha-mediated apoptosis. S Brouard PO Berberat E Tobiasch MP Seldon FH Bach MP Soares, J Biol Chem 2002 277 17950 17961 10.1074/jbc.M108317200 11880364
47. Carbon monoxide inhibition of apoptosis during ischemia-reperfusion lung injury is dependent on the p38 mitogen- activated protein kinase pathway and involves caspase-3. X Zhang P Shan LE Otterbein SS Zhang LE Otterbein XY Fu PJ Lee, J Biol Chem 2003 278 1248 1258 10.1074/jbc.M208419200 12399465